Literature DB >> 8263149

Relationship of sex hormones to lipids and lipoproteins in nondiabetic men.

S M Haffner1, L Mykkänen, R A Valdez, M S Katz.   

Abstract

Although many studies show that increased androgenicity is associated with increased triglyceride (TG) and decreased high density lipoprotein cholesterol in both pre- and postmenopausal women, relatively few data are available on the association of sex hormones to lipids and lipoproteins in men. We examined the association of sex hormone-binding globulin (SHBG), total and free testosterone, dehydroepiandrosterone sulfate (DHEA-SO4), and estradiol with lipids and lipoproteins in 178 nondiabetic men from the San Antonio Heart Study, a population-based study of diabetes and cardiovascular disease. The TG concentration was significantly inversely related to SHBG (r = -0.22), free testosterone (r = -0.15), total testosterone (r = -0.22), and DHEA-SO4 (r = -0.16). High density lipoprotein (HDL) cholesterol was significantly positively correlated to SHBG (r = 0.21), free testosterone (r = 0.15), total testosterone (r = 0.17), and DHEA-SO4 (r = 0.16). Total testosterone was significantly related to total cholesterol (r = -0.17) and low density lipoprotein cholesterol (r = -0.15). After adjustment for age, body mass index, waist to hip ratio, and glucose and insulin concentrations, TG concentrations remained significantly related to SHBG (r = -0.20), free testosterone (r = -0.15), and DHEA-SO4 (r = -0.18), and HDL cholesterol remained significantly associated with SHBG (r = 0.17), free testosterone (r = 0.15), total testosterone (r = 0.14), and DHEA-SO4 (r = 0.16). In conclusion, we observed a less atherogenic lipid and lipoprotein profile with increased testosterone concentrations. This was not explained by differences in glucose or insulin concentrations. However, sex hormones explained only a small percentage of the variation in total TG and HDL cholesterol concentrations. These findings are in striking contrast to data from women, in whom increased androgenicity is strongly associated with increased TG and decreased HDL cholesterol levels.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8263149     DOI: 10.1210/jcem.77.6.8263149

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  48 in total

1.  Clinical correlates of sex steroids and gonadotropins in men over the late adulthood: the Framingham Heart Study.

Authors:  R Haring; V Xanthakis; A Coviello; L Sullivan; S Bhasin; H Wallaschofski; J M Murabito; R S Vasan
Journal:  Int J Androl       Date:  2012-05-29

2.  Endogenous testosterone and the prospective association with carotid atherosclerosis in men: the Tromsø study.

Authors:  T Vikan; S H Johnsen; H Schirmer; I Njølstad; J Svartberg
Journal:  Eur J Epidemiol       Date:  2009-03-05       Impact factor: 8.082

Review 3.  Role of Testosterone in the Treatment of Cardiovascular Disease.

Authors:  Carolyn M Webb; Peter Collins
Journal:  Eur Cardiol       Date:  2017-12

4.  Association between Testosterone and Mortality Risk among U.S. Males Receiving Dialysis.

Authors:  Jerry Yu; Vanessa A Ravel; Amy S You; Elani Streja; Matthew B Rivara; Praveen K Potukuchi; Steven M Brunelli; Csaba P Kovesdy; Kamyar Kalantar-Zadeh; Connie M Rhee
Journal:  Am J Nephrol       Date:  2017-09-01       Impact factor: 3.754

5.  An update on testosterone, HDL and cardiovascular risk in men.

Authors:  Arthi Thirumalai; Katya B Rubinow; Stephanie T Page
Journal:  Clin Lipidol       Date:  2015

6.  Testosterone is negatively associated with the severity of coronary atherosclerosis in men.

Authors:  Li Li; Chang-Yan Guo; En-Zhi Jia; Tie-Bing Zhu; Lian-Sheng Wang; Ke-Jiang Cao; Wen-Zhu Ma; Zhi-Jian Yang
Journal:  Asian J Androl       Date:  2012-10-08       Impact factor: 3.285

7.  Sex-specific action of insulin to acutely increase the metabolic clearance rate of dehydroepiandrosterone in humans.

Authors:  J E Nestler; Z Kahwash
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

8.  Metabolic phenotype in the brothers of women with polycystic ovary syndrome.

Authors:  Susan Sam; Andrea D Coviello; Yeon-Ah Sung; Richard S Legro; Andrea Dunaif
Journal:  Diabetes Care       Date:  2008-03-10       Impact factor: 19.112

9.  Adverse effects of androgen deprivation therapy in prostate cancer: Current management issues.

Authors:  Aditya Bagrodia; Christopher J Diblasio; Robert W Wake; Ithaar H Derweesh
Journal:  Indian J Urol       Date:  2009-04

Review 10.  Welcoming low testosterone as a cardiovascular risk factor.

Authors:  M Maggio; S Basaria
Journal:  Int J Impot Res       Date:  2009-06-18       Impact factor: 2.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.